First, we assessed whether the pan-RAF inhibitor, TAK-580, specifically inhibits key proteins in the RAS-RAF-MEK-ERK pathway in MM cells using western blot analysis. This evidence concerns the gene MAP2K7 and Miyoshi myopathy.